UW Medicine’s Emergency Operations Center (EOC) reports on our ability to maintain normal operations using a scale from “monitoring” to “high level of activation” based on information about community transmission rates, hospital admissions, staffing capacity, space availability, PPE supplies and other impacts on the health system. This update provides a quick look at some of the key data used by the EOC to determine UW Medicine’s current level of activation. For more detailed information, you can review the EOC’s situation status reports.
EOC Level of Activation
April 12, 2022: The EOC is at a Low-Mid Level of Activation based on current numbers for COVID-19 admissions and community transmission. COVID-19 patients represent 1.07% of hospital admissions. UW Medicine hospitals are caring for 12 patients with COVID-19.
UW Medicine COVID-19 Inpatients
Daily Capacity Data Report
The Daily Capacity Data Report shows the total occupancy and the number of COVID-19 patients at each hospital.
King County and Washington State Epidemiology
King County: Public Health – Seattle & King County is reporting 381,612 cases and 2,714 deaths as of April 11. The number of new cases over the last seven days is currently at 140.7 per 100,000 people.
Washington: The Department of Health reports 1,467,059 total cases and 12,566 deaths as of April 7.
EOC Priorities
Community Transmission Rates (Continuing): The EOC is monitoring transmission rates in King County for potential impacts on hospitalizations. While the number of COVID-19 inpatients remains low, the seven-day rate of new cases per 100,000 people has increased from 50.5 on March 21 to 140.7 today.
Visitor’s Policy (New): Harborview Medical Center will allow one to two visitors daily beginning Wednesday, April 13, in alignment with the current policy at UW Medical Center. Visitation will continue to be subject to each facility’s specific hours and policies. See Visitor Restriction Policy for details.
COVID-19 Therapeutics (New): UW Medicine is increasing patient outreach for Evusheld to patients who are at the highest risk of developing severe illness from COVID-19. Evusheld is a monoclonal antibody therapy for pre-exposure prevention. A self-attestation process confirming eligibility will allow patients to request an appointment. Provider referrals are also accepted. The need for additional capacity will be assessed based on patient demand.
Stay Informed
Employee News:
- Dr. John Lynch COVID-19 Update (April 7)
In the Media:
- How the COVID-19 pandemic has taken a toll on heart health, Dr. Arun Sridhar, Cardiology, CNET
- Pandemic is leaving U.S. with shortage of long-term health care workers, Bianca Frogner, Family Medicine, U.S. News & World Report
- Pandemic anxiety was hard on IBS patients. How to find relief, Kendra Kamp, Gastroenterology, NPR
- Long COVID grips some Washingtonians and perplexes scientists; new research underway, Dr. Janna Friedly, Rehabilitation Medicine, The Seattle Times
Ongoing communications:
- Emergency Operations Updates: Scheduled for Tuesdays.
- Dr. John Lynch COVID-19 Update: Scheduled for Thursdays every two weeks.
- Town Halls: Generally scheduled for 3 p.m. on Fridays; Check your email for announcements (recordings available).
- Community Conversations: Check you email for dates and times (recordings available).
- EOC Situation Reports: Posted on the UW Medicine intranet (AMC login required).
- Leadership Messages and Employee Resources: Posted on The Huddle.
Sincerely,
UW Medicine Leadership
